Genmab A/S
1253 Copenhagen, K, Denmark (Map) Phone: +45-7020-2728
Fax: +45-7020-2729
Primary US Office:
Subscribers Only http://www.genmab.com
Overview
Genmab analyzes genomes in its lab. The biotech company creates and develops human antibodies to treat such conditions as lymphoma and other cancers, as well as autoimmune and inflammatory diseases. It has assembled a portfolio of products under its HuMax brand that are in different stages of development, ranging from pre-clinical to late-stage trials. In addition to developing its HuMax products, Genmab is working to create products for conditions such as infectious diseases and vascular conditions. The company has licensing and development partnerships with several international pharmaceutical and biotech companies including GlaxoSmithKline, Amgen, Medarex, and Roche. Genmab was founded in 1999.
Sample OverviewKey Numbers from Hoover's UK
Key financials for Genmab A/S
| Company Type | Public (Copenhagen: GEN) |
|---|---|
| Fiscal Year-End | December |
Key People from Hoover's UK
Key people and executives for Genmab A/S
| Chairman | Michael B. Widmer (Subscribers see complete biographies -- view sample)
Connect to this executive |
|---|---|
| President, CEO, and Director | Lisa N. Drakeman Connect to this executive |
| EVP and COO | Claus J. Møller-San Pedro Connect to this executive |
Top Competitors from Hoover's UK
Top competitors of Genmab A/S
There are 14 competitors for Genmab; see more.
